Neuromodulation in 2035: the neurology future forecasting series
T Denison, MJ Morrell - Neurology, 2022 - AAN Enterprises
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
Neuromodulation in 2035: The Neurology future forecasting series
TJ Denison, MJ Morrell - Neurology, 2022 - ora.ox.ac.uk
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
Neuromodulation in 2035: The Neurology Future Forecasting Series
T Denison, MJ Morrell - Neurology, 2022 - ingentaconnect.com
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
Neuromodulation in 2035: The Neurology Future Forecasting Series.
T Denison, MJ Morrell - Neurology, 2022 - europepmc.org
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
Neuromodulation in 2035: The Neurology Future Forecasting Series
T Denison, MJ Morrell - Neurology, 2022 - pubmed.ncbi.nlm.nih.gov
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
[HTML][HTML] Neuromodulation in 2035: The Neurology Future Forecasting Series
T Denison, MJ Morrell - Neurology, 2022 - ncbi.nlm.nih.gov
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
Neuromodulation in 2035: The Neurology Future Forecasting Series.
T Denison, MJ Morrell - Neurology, 2022 - europepmc.org
Neuromodulation devices are approved in the United States for the treatment of movement
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …
disorders, epilepsy, pain, and depression, and are used off-label for other neurologic …